Castle Biosciences grants 204,925 inducement RSUs to 172 employees under 2022 plan

Castle Biosciences

Castle Biosciences

CSTL

0.00
  • Castle Biosciences granted RSUs to 172 newly hired employees covering 204,925 common shares under its 2022 Inducement Plan.
  • The awards were granted on June 15, 2026.
  • RSUs vest over four years, with 25% on the first anniversary of the vesting start date.
  • The remaining shares vest annually in three equal installments, subject to continued service through each vesting date.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Castle Biosciences Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202606190700PR_NEWS_USPR_____DA87410) on June 19, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.